We have located links that may give you full text access.
Prognostic value of a novel artificial intelligence-based coronary CTA-derived ischemia algorithm among patients with normal or abnormal myocardial perfusion.
Journal of Cardiovascular Computed Tomography 2024 April 25
BACKGROUND: Among patients with obstructive coronary artery disease (CAD) on coronary computed tomography angiography (CTA), downstream positron emission tomography (PET) perfusion imaging can be performed to assess the presence of myocardial ischemia. A novel artificial-intelligence-guided quantitative computed tomography ischemia algorithm (AI-QCTischemia ) aims to predict ischemia directly from coronary CTA images. We aimed to study the prognostic value of AI-QCTischemia among patients with obstructive CAD on coronary CTA and normal or abnormal downstream PET perfusion.
METHODS: AI-QCTischemia was calculated by blinded analysts among patients from the retrospective coronary CTA cohort at Turku University Hospital, Finland, with obstructive CAD on initial visual reading (diameter stenosis ≥50%) being referred for downstream 15 O-H2 O-PET adenosine stress perfusion imaging. All coronary arteries with their side branches were assessed by AI-QCTischemia . Absolute stress myocardial blood flow ≤2.3 ml/g/min in ≥2 adjacent segments was considered abnormal. The primary endpoint was death, myocardial infarction, or unstable angina pectoris. The median follow-up was 6.2 [IQR 4.4-8.3] years.
RESULTS: 662 of 768 (86%) patients had conclusive AI-QCTischemia result. In patients with normal 15 O-H2 O-PET perfusion, an abnormal AI-QCTischemia result (n = 147/331) vs. normal AI-QCTischemia result (n = 184/331) was associated with a significantly higher crude and adjusted rates of the primary endpoint (adjusted HR 2.47, 95% CI 1.17-5.21, p = 0.018). This did not pertain to patients with abnormal 15 O-H2 O-PET perfusion (abnormal AI-QCTischemia result (n = 269/331) vs. normal AI-QCTischemia result (n = 62/331); adjusted HR 1.09, 95% CI 0.58-2.02, p = 0.794) (p-interaction = 0.039).
CONCLUSION: Among patients with obstructive CAD on coronary CTA referred for downstream 15 O-H2 O-PET perfusion imaging, AI-QCTischemia showed incremental prognostic value among patients with preserved perfusion by 15 O-H2 O-PET imaging, but not among those with reduced perfusion.
METHODS: AI-QCTischemia was calculated by blinded analysts among patients from the retrospective coronary CTA cohort at Turku University Hospital, Finland, with obstructive CAD on initial visual reading (diameter stenosis ≥50%) being referred for downstream 15 O-H2 O-PET adenosine stress perfusion imaging. All coronary arteries with their side branches were assessed by AI-QCTischemia . Absolute stress myocardial blood flow ≤2.3 ml/g/min in ≥2 adjacent segments was considered abnormal. The primary endpoint was death, myocardial infarction, or unstable angina pectoris. The median follow-up was 6.2 [IQR 4.4-8.3] years.
RESULTS: 662 of 768 (86%) patients had conclusive AI-QCTischemia result. In patients with normal 15 O-H2 O-PET perfusion, an abnormal AI-QCTischemia result (n = 147/331) vs. normal AI-QCTischemia result (n = 184/331) was associated with a significantly higher crude and adjusted rates of the primary endpoint (adjusted HR 2.47, 95% CI 1.17-5.21, p = 0.018). This did not pertain to patients with abnormal 15 O-H2 O-PET perfusion (abnormal AI-QCTischemia result (n = 269/331) vs. normal AI-QCTischemia result (n = 62/331); adjusted HR 1.09, 95% CI 0.58-2.02, p = 0.794) (p-interaction = 0.039).
CONCLUSION: Among patients with obstructive CAD on coronary CTA referred for downstream 15 O-H2 O-PET perfusion imaging, AI-QCTischemia showed incremental prognostic value among patients with preserved perfusion by 15 O-H2 O-PET imaging, but not among those with reduced perfusion.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app